221 related articles for article (PubMed ID: 11978783)
1. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum.
Dangoria NS; DeLay ML; Kingsbury DJ; Mear JP; Uchanska-Ziegler B; Ziegler A; Colbert RA
J Biol Chem; 2002 Jun; 277(26):23459-68. PubMed ID: 11978783
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.
Allen RL; O'Callaghan CA; McMichael AJ; Bowness P
J Immunol; 1999 May; 162(9):5045-8. PubMed ID: 10227970
[TBL] [Abstract][Full Text] [Related]
3. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface.
Carreno BM; Hansen TH
Eur J Immunol; 1994 Jun; 24(6):1285-92. PubMed ID: 8206088
[TBL] [Abstract][Full Text] [Related]
4. The amino acid at position 97 is involved in folding and surface expression of HLA-B27.
Blanco-Gelaz MA; Suárez-Alvarez B; González S; López-Vázquez A; Martínez-Borra J; López-Larrea C
Int Immunol; 2006 Jan; 18(1):211-20. PubMed ID: 16361312
[TBL] [Abstract][Full Text] [Related]
5. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling.
Bird LA; Peh CA; Kollnberger S; Elliott T; McMichael AJ; Bowness P
Eur J Immunol; 2003 Mar; 33(3):748-59. PubMed ID: 12616495
[TBL] [Abstract][Full Text] [Related]
6. The immunobiology of HLA-B27: variations on a theme.
Colbert RA
Curr Mol Med; 2004 Feb; 4(1):21-30. PubMed ID: 15011956
[TBL] [Abstract][Full Text] [Related]
7. Formation of HLA-B27 homodimers and their relationship to assembly kinetics.
Antoniou AN; Ford S; Taurog JD; Butcher GW; Powis SJ
J Biol Chem; 2004 Mar; 279(10):8895-902. PubMed ID: 14684742
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum degradation-enhancing α-mannosidase-like protein 1 targets misfolded HLA-B27 dimers for endoplasmic reticulum-associated degradation.
Guiliano DB; Fussell H; Lenart I; Tsao E; Nesbeth D; Fletcher AJ; Campbell EC; Yousaf N; Williams S; Santos S; Cameron A; Towers GJ; Kellam P; Hebert DN; Gould KG; Powis SJ; Antoniou AN
Arthritis Rheumatol; 2014 Nov; 66(11):2976-88. PubMed ID: 25132672
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the F Pocket of HLA-B27 Subtypes Strongly Affect Assembly, Chaperone Interactions, and Heavy-Chain Misfolding.
Guiliano DB; North H; Panayoitou E; Campbell EC; McHugh K; Cooke FG; Silvestre M; Bowness P; Powis SJ; Antoniou AN
Arthritis Rheumatol; 2017 Mar; 69(3):610-621. PubMed ID: 27723268
[TBL] [Abstract][Full Text] [Related]
10. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading.
Peh CA; Burrows SR; Barnden M; Khanna R; Cresswell P; Moss DJ; McCluskey J
Immunity; 1998 May; 8(5):531-42. PubMed ID: 9620674
[TBL] [Abstract][Full Text] [Related]
11. The MHC Class I heavy chain structurally conserved cysteines 101 and 164 participate in HLA-B27 dimer formation.
Lenart I; Guiliano DB; Burn G; Campbell EC; Morley KD; Fussell H; Powis SJ; Antoniou AN
Antioxid Redox Signal; 2012 Jan; 16(1):33-43. PubMed ID: 21902594
[TBL] [Abstract][Full Text] [Related]
12. HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP.
Tran TM; Satumtira N; Dorris ML; May E; Wang A; Furuta E; Taurog JD
J Immunol; 2004 Apr; 172(8):5110-9. PubMed ID: 15067095
[TBL] [Abstract][Full Text] [Related]
13. HLA-B27 misfolding and spondyloarthropathies.
Colbert RA; DeLay ML; Layh-Schmitt G; Sowders DP
Prion; 2009; 3(1):15-26. PubMed ID: 19363299
[TBL] [Abstract][Full Text] [Related]
14. HLA-B27 misfolding and ankylosing spondylitis.
Colbert RA; Tran TM; Layh-Schmitt G
Mol Immunol; 2014 Jan; 57(1):44-51. PubMed ID: 23993278
[TBL] [Abstract][Full Text] [Related]
15. HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation.
Blanco-Gelaz MA; Suárez-Alvarez B; Díaz-Peña R; López-Larrea C
Mol Immunol; 2009 Apr; 46(7):1304-11. PubMed ID: 19167761
[TBL] [Abstract][Full Text] [Related]
16. From HLA-B27 to spondyloarthritis: a journey through the ER.
Colbert RA; DeLay ML; Klenk EI; Layh-Schmitt G
Immunol Rev; 2010 Jan; 233(1):181-202. PubMed ID: 20193000
[TBL] [Abstract][Full Text] [Related]
17. Targeted Delivery of the HLA-B
Yu HC; Huang KY; Lu MC; Huang HL; Liu SQ; Lai NS; Huang HB
Mediators Inflamm; 2017; 2017():4016802. PubMed ID: 29463951
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic Folding Properties of the HLA-B27 Heavy Chain Revealed by Single Chain Trimer Versions of Peptide-Loaded Class I Major Histocompatibility Complex Molecules.
Lenart I; Truong LH; Nguyen DD; Rasiukienė O; Tsao E; Armstrong J; Kumar P; McHugh K; Pereira BI; Maan BS; Garstka MA; Bowness P; Blake N; Powis SJ; Gould K; Nesbeth D; Antoniou AN
Front Immunol; 2022; 13():902135. PubMed ID: 35958592
[TBL] [Abstract][Full Text] [Related]
19. Differential oxidation of HLA-B2704 and HLA-B2705 in lymphoblastoid and transfected adherent cells.
Saleki K; Hartigan N; Lith Mv; Bulleid N; Benham AM
Antioxid Redox Signal; 2006; 8(3-4):292-9. PubMed ID: 16677075
[TBL] [Abstract][Full Text] [Related]
20. An unstable beta 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide.
Sugita M; Brenner MB
J Exp Med; 1994 Dec; 180(6):2163-71. PubMed ID: 7964491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
